Type II collagen (CII) is of immunological interest because of its repetitive structure and properties as an autoantigen. The mouse gene has recently been cloned, thus enabling T cell-defined epitopes to be identified. Multiple novel epitopes on mouse CII are here detected in the autoreactive T cell response. The major response is directed to an epitope with residues 707-721 located on the CB10 fragment. Some 25 other epitopes are also recognized, including the autologous homologue of the 256-270 epitope which dominates in the response to foreign collagen. The cells reactive with mouse collagen peptides were of T h 1 type, as judged by release of IFN-γ. No significant reactivity was detected to mouse CII peptides during ongoing disease. Alignment of the mouse epitopes revealed a sequence motif with characteristic side chains at residues P1, P4 and P7, and to a lesser extent at P5, within a nonamer core sequence. Binding of these epitopes was simulated in a computer model of the I-A q molecule, where peptides with anchor residues at P1, P4 and P7 were indeed found to fit the binding groove best. The spacing of pockets and the fine structure of the binding surface of the I-A q molecule meshes with the repetitive structure of the collagen (X-Y-Gly), thus providing a likely explanation for the occurrence of multiple epitopes. Comparison with human DR binding motifs showed that the I-A q motif resembles most closely that of the DR4 subtypes which predispose for rheumatoid arthritis.
Introduction
Collagen molecules are the main structural proteins of connective tissue. They consist of three polypeptide chains forming an extended triple helical structure with a unique X-Y-Gly repetitive sequence. The extracellular matrix of cartilage is unique (along with the vitreous body of the eye) in containing collagens mainly of type II (CII), but also of types IX and XI, as well as type X (only in hypertrophic cartilage) (1, 2) . CII has recently been cloned from the mouse and its entire sequence of 1419 amino acids determined (3) . The repetitive structure of collagens makes them different from the more globular proteins usually used in T cell epitope analyses.
ing self-protein. This condition can convert into one apparently sustained by, as well targeted at, self CII: after adoptive transfer of cells from immunized donor mice, immunity can develop without need for further boosting with immunogen (13) and certain hybrid mice occasionally develop a relapsing form of the disease (14) . Furthermore, self CII induces a mild, relapsing disease, but only in mouse strains capable of responding to immunization with the foreign protein (15) (16) (17) . It was not known which epitopes on mouse CII are involved initially nor whether autoreactivity then spreads to other self epitopes, as occurs in EAE (18) .
The possibility that CII may act as an autoantigen in rheumatoid arthritis has received support (19) (20) (21) . However, no correlation was found between antibody titres to CII and HLA type nor with disease severity (23, 24) and has been observed with several other candidate autoantigens.
The aim of the present study was to analyse the T cell response of I-A q mice to self CII, using the newly available sequence data and the model of the I-A q molecule.
Methods

Synthesis of mouse CII peptides
A complete series of 280 mouse CII peptide 15mers, overlapping by 12 amino acids, was synthesized on a milligram scale ('tip-method') on a SYRO roboter (MultiSyntec, Bochum, Germany), using Fmoc/But chemistry (25) . The panel spanned amino acid residues 86-925 of the mouse CII triple helix, as well as the N-terminal and C-terminal collagen propeptides (3) . Each peptide was acetylated at the N-terminus and amidated at the C-terminus. The quality was assessed by HPLC and mass spectroscopy of 15 sample peptides, which displayed the expected mol. wt and spectrum. Peptide mCII 707-721 (PPG ANG NPG PAG PPG) and the corresponding mouse type I collagen peptides mCI 707-721 (PPG PSG NAG PPG PPG) and mCII 256-270 (GEPG IAG FKG EQG PKG ETG) were also synthesized (Applied Biosystems Peptide Synthesizer: 432A-Synergy), purified by reversed-phase HPLC, amidated at the C-terminus, and the structure again confirmed by mass spectroscopy.
Preparation of CII
Mouse CII was extracted from xiphisterna by pepsin digestion (26) and further purified by salt precipitation (27) . Rat CII was purified from the Swarm chondrosarcoma (28) . The collagens were dissolved in 0.1 M acetic acid. Collagen for use in restimulating primed lymph node cells (LNC) was denatured by incubating at 56°C for 30 min.
Production of recombinant collagen fragments by cloning and expression of segments of the mouse CII cDNA
Oligonucleotide primers were used to amplify segments of the mouse CII gene by PCR from clones covering the entire coding sequence, provided by E. Vuorio, Turku (3). The PCR was run at 94°C for 1.5 min, with annealing at 50°C for 1.5 min and extension at 72°C for 1.5 min, in 35 reaction cycles. The primers included restriction sites, EcoRI (5Ј primers) and HindIII (3Ј primers), to allow the amplified fragments to be inserted into the pMAL-c2 expression vector (New England Biolabs, Beverly, MA) in the same translational reading frame as the malE gene in the vector. A stop codon (UGA) was added to the 3Ј primers for correct termination. Fusion proteins were expressed in Escherichia coli Xl-1 blue cells (Stratagene, La Jolla, CA) and purified according to the manufacturer's instructions, with yields of 5-50 mg protein/l. Purity was evaluated by SDS-PAGE (29) . Fusion proteins were digested by factor Xa (New England Biolabs) before use for immunization, to avoid problems with flanking residues. The oligonucleotide primers were synthesized by TIB MOLBIOL (Berlin, Germany), as follows. Exon 1-8 of mouse CII cDNA (3): a1: 5Ј-GATCGAATTCCTCATCGCCGCGGTCC a2: 5Ј-GATCAAGCTTCAAGGTTCTCCTTTCTGC a12: 5Ј-GATCGAATTCCTACGGTGTCAGGGCC a22: 5Ј-GATCAAGCTTCATCGACCACTGGCAGTG a3: 5Ј-GATCGAATTCCCAGCTGACCTCGCCA a4: 5Ј-GATCAAGCTTCAAAGGCCAGGGGGACCA a5: 5Ј-GATCGAATTCCCTGGTACCCCTGGAA a6: 5Ј-GATCAAGCTTCAAAATCCTTGAGGGCCG Exon 6-18 b1: 5Ј-GATCGAATTCCCCATGGGCCCCATGG  b2: 5Ј-GATCAAGCTTCACGGGGATCCGTTCTCA  b3: 5Ј-GATCGAATTCGAAGCTGGTGCTCCGG  b4: 5Ј-GATCAAGCTTCAACCAGAAGCACCTGCA  Exon 16-24  c1: 5Ј-GATCGAATTCGGTCCTGAAGGTGCT  c2: 5Ј-GATCAAGCTTCAACGGGGCCCAGGGAAG  c3: 5Ј-GATCGAATTCCGAGGTGCTCGAGGAG  c4: 5Ј-GATCAAGCTTCAGGCTCCAGGAAGACCA  Exon 21-36  d1: 5Ј-GATCGAATTCGGTCCCAAGGGAGCCA  d2: 5Ј-GATCAAGCTTCAGCCCTGCTCGCCTCGT  d3: 5Ј-GATCGAATTCACGGGAGCCGCAGGAC  d4: 5Ј-GATCAAGCTTCAAGCCCCAGGGGGGCCA  d5: 5Ј-GATCGAATTCGGCACTCCTGGTACTG  d6: 5Ј-GATCAAGCTTCAAGCAGGTCCAGGTGGC  Exon 35-49 (middle)  e1: 5Ј-GATCGAATTCAGTACCGGAGCTCGAG  e2: 5Ј-GATCAAGCTTCATCCAGCAGGACCAGGG  e3: 5Ј-GATCGAATTCCGAGTTGGACCCCCAG  e4: 5Ј-GATCAAGCTTCAAGACGCGCCAGGTGCA  e5: 5Ј-GATCGAATTCGGATTCCCCGGCCTTC  e6: 5Ј-GATCAAGCTTCAAGCAGGTCCTGAGGGA  e7: 5Ј-GATCGAATTCGGCAAACAAGGAGACA  e8: 5Ј-GATCAAGCTTCATGAGCGTCCACGGGA  e9: 5Ј-GATCGAATTCGGCAAAGATGGCTCTA  e10: 5Ј-GATCAAGCTTCAACTGTCTGCCTCGTCG  Exon 49-f1: 5Ј-GATCGAATTCGGGCAGAGAGAGAAGG  f2: 5Ј-GATCAAGCTTCAGCTGCTCCACCAGTTT  f3: 5Ј-GATCGAATTCGGCGAGACTTGCGTCT  f4: 5Ј-GATCAAGCTTCACTCTACATCATTGGAG  f5: 5Ј-GATCGAATTCGACGAAGCGGCTGGCA  f6: 5Ј-GATCAAGCTTCACAAGAAGCAGACAGGC
Immunization of mice and induction of arthritis
To test proliferative responses and cytokine release in draining LNC, male (B10.QϫDBA/1)F 1 mice, 7-10 weeks of age, were immunized in each hind footpad with 50 µg mouse CII or synthetic peptide emulsified in CFA (containing H37Ra; Difco, Detroit, MI). For immunization with recombinant collagen fragments, mice were injected in each hind footpad with 50 µl of protease Xa digested fusion protein that had not been further purified containing 2.5-5 nmol of the recombinant peptide, emulsified 1:1 in CFA-H37Ra (5-to 10-fold molar excess over the mouse CII as used for immunization, 1 nmol). Arthritis was induced in the same type of mouse at 7-10 weeks of age, by immunizing mice at the base of the tail with 100 µg rat CII emulsified in CFA. After 5 weeks, mice were boosted with 50 µg rat CII emulsified 1:1 in incomplete Freund's adjuvant (IFA; Difco). Lymph nodes draining severely arthritic joints from these mice were then removed and pooled to test reactivity to the panel of mouse CII peptides in a proliferation assay.
In vitro proliferation assays
Popliteal lymph nodes from immunized mice were pooled 14 days after immunization and a single-cell suspension prepared. The medium was DMEM supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 10 mM HEPES, 50 µM 2-mercaptoethanol and 1% normal mouse serum, prepared freshly from male mice (frozen serum was found inhibitory in cell culture), cultures were at 6ϫ10 6 cells/ml and 100 µl/well in 96-well flat-bottom plates for 96 h, followed by pulsing for an additional 18 h with 1 µCi [ 3 H]thymidine (Amersham, Buckinghamshire, UK). Low c.p.m. but also low backgrounds were obtained on a gas-flow counter. Purified protein derivative (PPD; Statens Serum Institut, Tuberculin Department, Copenhagen, Denmark) served as positive control in the assays at a final concentration of 10 µg/ml.
MACS
Lymph node cells from mice primed with mouse CII were depleted of either T cells or B cells by passage through MACS using super-paramagnetic microbeads conjugated with monoclonal rat anti-mouse L3T4 (CD4) antibodies, or rat anti-mouse B220 (CD45R), (Miltenyi Biotec, Bergisch Gladbach, Germany), as recommended by the manufacturer except that PBS containing 2% FCS, 5 mM EDTA, 50 µM 2-mercaptoethanol and 10 mM HEPES was substituted for PBS/BSA buffer. The fractions were analyzed on a FACScan flow cytometer (Becton Dickinson) using FITC-conjugated anti-mouse CD8a (Ly-2) and R-phycoerythrin-conjugated antimouse-CD3ε for staining T cells, and FITC-anti-mouse-κ-light chain for B cells (PharMingen, San Diego, CA). The cells were washed 3 times with DMEM medium without serum after separation and then put into proliferation assays. Enriched CD4 ϩ T cells were mixed together with spleen cells from syngeneic mice as antigen-presenting cells (APC) in a ratio of 1:2. APC were a single-cell suspension from spleens treated with 0.84% NH 4 Cl, pH 7.4, to lyse red blood cells.
Quantitative IFN-γ and IL-4 ELISA
Cytokine releases were assayed from 50 µl supernatants of primary cultures of mouse CII-primed LNC re-stimulated in vitro with the panel of CII peptides using IFN-γ and IL-4 kits (Endogen, Cambridge, MA).
Simulation of peptide binding to the I-A q molecule
The model of the I-A q molecule was built from that of the HLA-DR1 molecule (11, 12) using the COMPOSER suite of programs (30) contained within SYBYL (Tripos Associates, St Louis, MO). In brief, the sequence of the I-A q chains was built into the coordinates of the MHC class II α and β chains of the HLA-DR1 influenza HA structure. Insertions and deletions relative to the DR1 sequence were built initially using the loop searching algorithms within COMPOSER and subjected to energy minimization.
To model the peptide, candidate residues for the P1 position were used to align the test sequence within the binding cleft. Alignments that gave unacceptable contacts were eliminated and the remaining alignments were ranked by inspection of the peptide side chain interactions with the MHC molecule, particularly those with the P1, P6 and P9 pockets, and by calculating interaction energies for those pockets (D. McCormick, pers. commun.). The optimal model was refined using a gradient torsional optimization algorithm (C. J. Thorpe, pers. commun.). Initially the main chain of the molecule and the C β carbons were fixed. Following the convergence of the side refinement all of the atoms of the molecule were released and the optimization was performed on the entire model.
Results
In vitro T cell responses of (B10.QϫDBA/1)F 1 mice to mouse CII
To map epitopes, a panel of overlapping 15mer mouse CII peptides was tested in proliferation and IFN-γ-release assays using LNC from mice of the H-2 q haplotype, primed with mouse CII. In addition, IL-4 was measured in the supernatants, to assess whether a T h 2-type cytokine was produced. Data from three repeated experiments are shown in Fig. 1(A) , aligned for comparison with the IFN-γ-release profile from a separate experiment in Fig. 1(B) . From these profiles core sequences critical for recognition were deduced from the sequences of the active peptides as compared with those of the adjacent non-stimulatory peptides, as described in detail in the legend of Table 1 . The epitopes identified in this way are listed in Table 1 .
T cell activity was found against a surprisingly large number of epitopes distributed over certain segments of the CII triple helix, which can thus be identified as immunogenic regions. Three regions identified in this way comprise residues 170-277, 335-397 and 587-793; the first two of these regions are located on the cyanogen bromide proteolysis fragment CB11 and the third in CB10. In contrast, there are entirely silent segments, such as 277-332 (CB11) and 397-587 which spans the entire CB8 fragment.
These epitopes on mouse CII constitute a hierarchy, as judged by the proliferative responses. The major responses were elicited with peptides 698-712 through 710-724, spanning two overlapping core sequences composed of the residues 704-712 and 710-718. Within this group of reactive peptides the strongest response was elicited by peptide 707-721 (stimulation index of 19.4 in the profile shown), which thus constitutes the immunodominant epitope Table 1 . Proliferative responses to intact mouse CII itself could not be detected in our experiments, although a weak stimulation index of 2 or less has been reported (31) . Altogether some 25 epitopes were recognized. The panel of peptides did not evoke significant proliferative responses in LNC from the same type of mice which were primed with CFA alone (data not shown).
The data from proliferation and IFN-γ release agree well (Fig. 1A) . The same immunogenic regions were detected in both assays, and the minimal epitopes 170-184, 185-199, 203-217, 218-232, 224-238, 230-244, 254-258, 341-349 and 707-721 were active in both (SI ജ 3, IFN-γ ജ 2 ng/ml). Some variation between the two assays could be detected. Thus peptides defining the core sequences 170-178, 203-211, 227-235, 233-241 and 260-268 induced proliferation 3-to 5-fold less actively than the major peptide 707-721, although IFN-γ released was similar. Further differences are evident in Fig. 2 , in which the IFN-γ-release profile is aligned for comparison with proliferative response profiles from two separate experiments. Peptides defining the core sequence 212-220 and 245-253 elicited proliferative responses without IFN-γ release. In contrast, peptides 161-175 and 164-179 induced weak IFN-γ release but no proliferation, except for a weak signal occasionally obtained with peptide 164-179 (see experiment 2) suggesting that the discrepancy might reflect different sensitivities of the two assays. The IFN-γ release as detected by ELISA appears overall to be the more sensitive. Interestingly, peptides defining the core sequences 263-270 and 704-712 evoked mainly proliferative responses (SI ϭ 18 and 5.6 respectively), with a disproportionately low IFN-γ release (1.0 ng/ml). The overlapping core sequence 260-268 Epitopes on the mouse CII triple helix that elicit response in autoreactive T cells in the H-2 q mice. From the proliferative and IFN-γ-release profiles shown in Fig. 1 , epitopes were identified as follows: by comparing the sequences of overlapping active peptides with the adjacent non-stimulatory peptides, residues critical for recognition of each epitope could be narrowed down to a nine amino acids sequence, designated here as the 'core sequence'. Amino acid residues constituting the core sequence are shown in bold or are underlined if the core could not be determined clearly, in which case the most likely core residues are underlined. In addition, by comparing activities within a group of peptides sharing a common core sequence, it could be inferred which of the peptides contained the flanking residues most important for recognition, assuming that they would be present in the peptide which consistently evoked the strongest response (referred to as 'peptide'). The stimulation indices and IFN-γ release from the experiment shown in Fig. 1 are listed. A small number of epitopes elicited response as judged either by proliferation or by IFN-γ release, but not both. They are indicated as follows: a only proliferative response was detected; b only IFN-γ release was measured; c indicates a minimal epitope based only on IFN-γ responses alone.
shifted only by three amino acids strongly induced release of IFN-γ. The overall pattern of reactivity was not altered in separate proliferation assays, as shown for the epitopes on the CB11 fragment in Fig. 2 .
IL-4 was measured in the culture supernatants. No significant IL-4 response was detected except to the peptides 107-121, 416-430, 419-433 and 608-622, which elicited weak responses (10-30 pg/ml in the culture supernatant, data not shown). No IL-4 release was detected from cells stimulated with PPD. The cells reactive with collagen peptides are of T h 1 type, secreting IFN-γ but not significant amounts of IL-4.
Detailed analysis of the response to the major epitope 707-721 and to the minor mouse epitope 256-270
The proliferative response to the major epitope 707-721 was further analysed over a concentration range from 0.019 to 0.3 mM. The stimulation index at the highest peptide concentration was 9.4 Ϯ 3.2 in LNC primed with mouse CII. No significant proliferative responses were elicited in LNC from mice primed with CFA alone (Fig. 3) . The peptide from the corresponding sequence of type I collagen did not evoke a proliferative response (data not shown). The peptide 707-721 synthesized by the 'tip method' induced proliferation more strongly, presumably because of the acetylation of the N-terminus.
In order to identify the responding cell population, LNC were depleted by MACS. The CD4 ϩ -depleted fraction did not proliferate in the presence of the peptide (∆c.p.m. 338 Ϯ 275), whereas that in the CD4 ϩ -enriched population was enhanced (∆c.p.m. 20,540 Ϯ 3640, compared with 13,190 Ϯ 4560 for the unfractionated LNC). Depletion of B cells did not reduce the proliferative response, indicating that B cells Proliferative responses in fractions of mouse CII-primed LNC in which T or B cells were selectively enriched or depleted from the bulk LNC population of (B10.QϫDBA/1)F 1 mice primed to the mouse CII. Poplitheal LNC from eight mice were pooled at day 14 and the CD4 ϩ T cells were depleted from the bulk LNC population by using magnetic bead-coupled anti-mouse CD4 antibodies. The in vitro proliferative responses of the bulk LNC population, CD4 ϩ enriched fraction (Ͼ85% purity) and CD4 ϩ depleted fraction (99 % purity) are shown in cultures of 6ϫ10 6 cells/well in the presence of mCII 707-721 at 0.15 mM. B cells were depleted from the bulk LNC population by using magnetic bead-coupled anti-mouse CD45R antibodies. The in vitro proliferative responses of the enriched B cell population (Ͼ95% purity) and of the B cell depleted fraction (Ͼ95% purity) is shown at a peptide concentration of 0.15 mM. neither recognize the peptide nor were important in its presentation. Thus it is the CD4 ϩ T cell population within the primed LNC which responds to the major peptide (Fig. 4) .
Arthritis could not be induced with the major peptide 707-721 by using the same immunization protocol as for the intact collagen, in agreement with the requirement of native CII for induction of CIA (32, 33) .
The response to the mouse epitope 256-270 was analysed in detail by immunizing mice with the peptide and restimulating LNC with the nested mouse peptides spanning the same residues. Reactivities were detected to peptides 251-265 through to 260-274, thus identifying two overlapping core sequences at 257-265 and 260-268, with stronger reactivity to the 260-268 core (Fig. 5A) . The proliferative response to the 260-268 core was further investigated by immunizing mice with their own type II collagen and restimulating primed LNC with the peptide 260-274 over a concentration range from 0.038 to 0.15 mM. A stimulation index of 4.2 Ϯ 1.6 was obtained at the highest peptide concentration (Fig. 5B) .
T cell proliferative responses to recombinant fragments of CII: a search for cryptic epitopes on mouse CII
Mice were immunized with recombinant mouse CII fragments (see Methods) in the hope of detecting cryptic epitopes, i.e. epitopes not revealed by immunization with the intact protein (34) . Eleven fusion proteins were purified containing collagen fragments of 33-110 amino acids in length and spanning the same region on the molecule as the overlapping synthetic peptides (Fig. 6B ). An additional five fragments were expressed but not purified. Altogether~75% of the mouse type II procollagen molecule were expressed, as outlined in Fig. 6(A) . The calculated and observed mol. wt of the purified proteins agreed well. One-step affinity chromatography yielded highly enriched fractions, as judged by SDS-PAGE, a few weakly stained additional bands could be detected to the main one. Immunization with these recombinant peptides did not reveal novel (cryptic) epitopes: the fragments 704-813, 291-356 and 245-277 induced responses to the same minimal epitopes as had been obtained with the intact protein (Fig. 7) ; the proliferative responses were weaker, indicating that the intact protein is a stronger immunogen.
In vitro T cell proliferative responses to mouse CII peptides of (B10.QϫDBA/1)F 1 mice immunized with rat CII
The T cell proliferative responses were tested towards the panel of mouse CII peptides in LNC primed with rat CII (~98% homologous with mouse CII). The pattern of reactivity and the hierarchy of recognition of mouse peptides was not significantly altered, except that T cells reacted most strongly to the core 704-712 than to the 710-718 major epitope evident after priming with mouse CII (Fig. 8) . In contrast to mouse CII-primed LNC, however, the strongest response was evoked by the rat 256-270 peptide, which differs in one amino acid from the homologous mouse peptide, and is also immunodominant on bovine, chicken and human CII (31) .
In vitro T cell proliferative responses to mouse CII peptides in lymph nodes draining severely arthritic joints
The proliferative response was also tested with the panel of mouse CII peptides, using cells from lymph nodes draining severely arthritic joints of mice injected with rat CII. No reactivity was detected (data not shown), although the PPD response was still intact (38,400 Ϯ 3700 c.p.m.) and a weak response could be detected to the foreign immunodominant epitope 256-270 (SI ϭ 3.6 Ϯ 1.1), as well as to rat CII (SI ϭ 2.6 Ϯ 1.2).
T cell reactivity usually becomes more difficult to detect late after immunization with CFA (35) and conversion of CIA to a disease driven by self-collagen occurs only occasionally (13, 14) .
Alignment of the core sequences of the autologous epitopes reveals a binding motif to the class II molecule I-A q
The core sequences were aligned to check for similarities in the amino acid sequence (Table 2 ). In the frame used here with P1 designating the first amino acid from the N-terminus of the core sequence, positions P3, P6 and P9 are occupied by glycine residues, as dictated by the sequence of CII in which every third residue is a glycine. Further, similar side chain characteristics are evident at positions P1, P4 and P7, and to a lesser extent at P5. At P1 and P4, amino acids with aromatic or aliphatic side chains are preferred, although at P4 Asn and Arg also occur. At P5, the positively charged amino acids Lys and Arg occur at above average frequency. At P7 a negatively charged residue is favored, with Glu occurring most commonly. Out of 24 aligned core sequences, 16 had Glu, Asp or the amide derivatives of these amino acids at this position, indicating a preference for the amino acids in the order E Ͼ D Ͼ Q Ͼ P Ͼ N, although an aliphatic side chain is also tolerated.
Discussion
The main finding here is of multiple novel epitopes in the mouse CII triple helical region operative in the autoreactive T cell response. Three large regions of the CII sequence contain peptides recognized by autoreactive T cells: two regions in the CB11 fragment and one in the CB10 fragment. The region located in the CB10 fragment gives the strongest response and seems to contain two epitopes, both located between positions 701-721. Some 25 other epitopes are also recog- nized including the autologous homologue of the 256-270 epitope which dominates in the response to foreign collagen (31) . The mouse sequence corresponding to this foreign epitope differs by one amino acid (Glu266 to Asp266 in mouse). It is recognized after immunization with the mouse peptide 256-270 but not with intact collagen (31), thus identifying it as cryptic (34) . In contrast, a response to the mouse epitope 256-270 is here detected after immunization with mouse CII and with the large recombinant peptide 245-277.
Residues flanking the mouse epitope 256-270 appear to influence its recognition, as immunization with mouse CII or the recombinant peptide 245-277 elicits a response to the overlapping epitopes 263-271 and 260-268. Mice primed with the 256-270 epitope show also a significant response to the peptide 251-265 (with the core sequence 257-265) suggesting that the C-terminal amino acids of 256-270 may be less important for the recognition or that the 251-265 region of the peptide is cryptic. Further, the finding parallels the recognition of two overlapping epitopes at residues 258-270 and 261-273 on bovine CII in HLA-DR4 transgenic mice (36) .
There are other minor similarities to the response to foreign collagens. A weak response is detected here to peptide 185-199, which is slightly displaced from the chicken co-dominant epitope 181-209 (37) . The dominant epitope recognized on chicken and bovine CII in RT1 u rats maps to residues 184-198 (38, 39) . Broad but weak responses have also been detected to diverse parts of foreign CII and it should be recalled that T cell responses to CII (including xenogeneic CII) are weak in general compared to responses to other globular proteins (40) (41) (42) .
The contrast here with the epitope distribution on foreign CII might reflect the absence of the immunodominant epitope on the mouse protein, which could allow weaker epitopes to participate in the response. This possibility is excluded by the similarity of reactivity to mouse peptides that was obtained with LNC primed to rat CII, even though the dominant foreign epitope is present in this molecule. The present findings suggest rather that reactivity to multiple epitopes on the mouse protein relates to the repeating structure of collagen.
Alignment of the mouse epitopes revealed a sequence motif which has characteristic side chains at residues P1, P4 and P7, and to a lesser extent at P5 within a nonamer core sequence. Computer-based docking studies of the I-A q molecule confirmed that peptides with anchor residues at P1, P4 and P7 in the protein indeed fitted the binding groove best. The glycine residues which occur at every third position coincide with binding pockets able to accommodate small Fig. 9 . Model of the CII peptide 254-268 binding to I-A q . A solvent accessible surface was generated for those residues, all or part of which lie within 5 Å of the peptide, and is represented in green in the figure. In this way some measure of the complementarity between the peptide binding site and the peptide, which is represented as CPK spheres, can be seen. Note, for example, that the phenylalanine residue at P4 fits into a shallow depression in the floor and side of the binding groove.
side chains. Residues at P5, P8 and P10 pointed away from the binding groove, provisionally identifying them as TCR contact residues. Thus, the spacing and binding specificities of the binding pockets of the I-A q molecule mesh with the repetitive structure of collagen (Fig. 9 ), which provides a likely explanation for the occurrence of multiple epitopes. In previous studies, replacement of Ile260, Phe263, K264 and Glu266 corresponding to residues at P1, P4, P5 and P7 in the I-A q motif reduced or entirely abrogated the response (40, 43, 44) . Comparison with human DR binding motifs showed that this I-A q motif resembles most closely that of DR4 (DRB1*0404, 0401 and 0405 subtypes), where side chains at P1, P4 and P7 contribute to binding to the MHC. In particular, the P7 pocket in DR4 prefers a polar, aliphatic or charged residue, as it does in the I-A q binding motif (45) . The DR4 subtypes mentioned above as having similar binding motifs to I-A q predispose for rheumatoid arthritis (46) (47) (48) .
To further evaluate the significance of the present evidence of meshing between the collagen repeat and this novel binding motif it would be helpful to determine whether similar binding motifs occur on other class II molecules associated with arthritis.
Recognition of an identical epitopes on chicken CII in RT1 u rats and in DR4 transgenic mice argues for this hypothesis. Detection of reactivity to multiple cyanogen bromide fragments on porcine type II collagen in mice of the H-2 r haplotype, also susceptible to CIA, also supports the meshing hypothesis (42) . Further, a different binding motif should be expected in class II molecules which confer resistance to CIA. This applies to the I-A b molecule associated with resistance to CIA (14) , which has a well documented motif (49) (large aromatic residues at P1 and P6), different from that of the I-A q motif proposed here.
The epitopes identified in this study may be relevant to rheumatoid arthritis. The findings do not augur well for rheumatoid arthritis therapies aimed at blocking the immune response to a single epitope, but do intricate the scope for bystander suppression (50) (51) .
LNC lymph node cells PPD purified protein derivative
